Michelle Rudek-Renaut

Associate Professor

19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michelle Rudek-Renaut is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Plasma (human) Chemical Compounds
temozolomide Medicine & Life Sciences
Tandem Mass Spectrometry Medicine & Life Sciences
Liquid chromatography Chemical Compounds
Mass spectrometry Chemical Compounds
Liquid Chromatography Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

AIDS-related Kaposi sarcoma, version 2.2019

Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., Carchman, E., Cohen, A., Crysler, O. V., Gupta, N., Gustafson, C., Hall, A., Johung, K. L., Klopp, A., LaCasce, A. S., Lin, C., Mehta, A., Menon, M. P., Morgan, D., Nathwani, N. & 11 others, Noy, A., Ratner, L., Rizza, S., Rudek-Renaut, M., Sanchez, J., Taylor, J., Tomlinson, B., Wang, C. C. J., Yendamuri, S., Dwyer, M. A. & Freedman-Cass, D. A., Feb 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 2, p. 171-189 19 p.

Research output: Contribution to journalArticle

Kaposi's Sarcoma
HIV
Acquired Immunodeficiency Syndrome
Skin
Practice Guidelines

A phase i trial of the VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced solid tumors and differentiated thyroid cancers

Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., O'Connor, A., Karunsena, E., Parkinson, R., Bishop, J. A., Ha, Y., Sharma, R., Gocke, C., Zinner, R., Rudek-Renaut, M., Sherman, S. I. & Azad, N., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5475-5484 10 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Mitogen-Activated Protein Kinase Kinases
Thyroid Neoplasms
Protein-Tyrosine Kinases
Neoplasms

Establishing an investigational drugs and research residency at an academic medical center

Wascher, M., Mighty, J., Brown, V., Ashby, D., Rudek, M. A., Nesbit, T., Delisa, A., Walker, C. & Tolan, M., Oct 17 2019, In : American Journal of Health-System Pharmacy. 76, 22, p. 1862-1867 6 p.

Research output: Contribution to journalArticle

Investigational Drugs
Internship and Residency
Research
Pharmacists
Credentialing

Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia

Sharma, A., Özayral, S., Caserto, J. S., Ten Cate, R., Anders, N., Barnett, J. D., Kandala, S. K., Henderson, E., Stewart, J., Liapi, E. A., Rudek-Renaut, M., Franken, N. A. P., Oei, A. L., Korangath, P., Bunz, F. & Ivkov, R., Jan 1 2019, In : International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 36, 1, p. 712-720 9 p.

Research output: Contribution to journalArticle

Open Access
Doxorubicin
Fever
Hot Temperature
HCT116 Cells
Heating

Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment

Saif, M. W., Rosen, L., Rudek-Renaut, M., Sun, W., Shepard, D. R., Becerra, C., Yamashita, F., Bebeau, P. & Winkler, R., Jan 1 2019, In : British Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

Trifluridine
Pharmacokinetics
Safety
Liver
Neoplasms